Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 141-145 of 145 for pancreatic cancer

Edit search filters
  1. Evaluating FDG PET-MRI-based Biomarkers In Borderline Resectable Pancreatic Cancer

    Rochester, MN

  2. AI Algorithm For Detection Of Pancreatic Ductal Adenocarcinoma

    Rochester, MN

  3. A Study Of Photon And Proton Chemoradiotherapy As Definitive Or Neoadjuvant Therapy In Non-Metastatic Pancreatic Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  4. A Study To Investigate Blood-derived Circulating Tumor DNA, Circulating Tumor RNA, And Circulating Tumor MiRNA In Pancreatic Cancer Patients

    Jacksonville, FL

  5. Project Survival-Prospective Biomarker Discovery

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer